News
1d
The Times of Israel on MSNIn first, Israeli researchers develop mRNA jab against antibiotic-resistant bacteriumScientists from Tel Aviv University and the Israel Institute of Biological Research say their vaccine uses lipid ...
Researchers from Tel Aviv University and the Israel Institute for Biological Research in Ness Ziona have used the platform ...
1d
Onlymyhealth on MSNWorld’s First mRNA Vaccine Against Bubonic Plague: Israeli Scientists Make HistoryIn a historic breakthrough for global medicine, Israeli researchers have made a ground-breaking development of the world’s ...
The team from Tel Aviv University developed a vaccine to combat the bacterium that causes the black plague, using the same ...
In this episode presented by Eclipsebio, BioSpace's head of insights Lori Ellis discusses mRNA and srRNA with Andy Geall of ...
Moderna's Spikevax receives FDA approval for use in high-risk children; Pfizer, BioNTech appeal U.K. ruling in COVID-19 ...
The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 ...
The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.
The approval of Moderna's Spikevax for kids at higher risk of contracting the disease continues the company's regulatory ...
Institutions like OMRF have had almost unbroken bipartisan support as a national biomedical research policy. Breaking it ...
The average short interest for the S&P 500 Health Care Index Sector (NYSEARCA:XLV) experienced an increase in June, moving ...
StockStory.org on MSN4d
Why Moderna (MRNA) Stock Is Up TodayShares of biotechnology company Moderna (NASDAQ:MRNA) jumped 3.8% in the morning session after the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results